
Recent Experiences with Regulation of Biosimilars at the FDA
Roundtable 15 Notes: WCBP 2024
Recent Experiences with Regulation of Biosimilars at the FDA

Roundtable 15 Notes: WCBP 2024
Recent Experiences with Regulation of Biosimilars at the FDA